Henry Schein (NASDAQ:HSIC) issued an update on its FY18 earnings guidance on Tuesday morning. The company provided EPS guidance of $4.06-4.14 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.12.
HSIC stock traded down $0.36 on Thursday, hitting $86.97. The company had a trading volume of 1,336,433 shares, compared to its average volume of 1,584,331. Henry Schein has a 12-month low of $62.56 and a 12-month high of $90.52. The company has a current ratio of 1.30, a quick ratio of 0.68 and a debt-to-equity ratio of 0.29. The stock has a market capitalization of $12.79 billion, a P/E ratio of 24.16, a P/E/G ratio of 2.56 and a beta of 0.87.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 6th. The company reported $1.03 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.01 by $0.02. Henry Schein had a net margin of 3.00% and a return on equity of 20.40%. The company had revenue of $3.28 billion for the quarter, compared to analysts’ expectations of $3.37 billion. During the same quarter last year, the company posted $0.87 earnings per share. The firm’s quarterly revenue was up 3.8% on a year-over-year basis. As a group, equities analysts predict that Henry Schein will post 4.11 earnings per share for the current year.
Several research analysts have weighed in on the stock. Morgan Stanley increased their price target on shares of Henry Schein from $65.00 to $66.00 and gave the stock an underweight rating in a research report on Tuesday, October 9th. Goldman Sachs Group reiterated a neutral rating on shares of Henry Schein in a research report on Friday, October 19th. ValuEngine upgraded shares of Henry Schein from a strong sell rating to a sell rating in a research report on Thursday, September 13th. Zacks Investment Research downgraded shares of Henry Schein from a buy rating to a hold rating in a research report on Thursday, August 2nd. Finally, Leerink Swann set a $100.00 price target on shares of Henry Schein and gave the stock a buy rating in a research report on Tuesday, August 7th. Two analysts have rated the stock with a sell rating, nine have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. The company has an average rating of Hold and a consensus target price of $84.41.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Article: Determine Your Level of Risk Tolerance
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.